{"context":{"query":">>hgnc>>msigdb","source_dataset":"hgnc","target_dataset":"msigdb"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]HGNC:1582,10,HGNC:1582,134,1]["},"schema":"id|standard_name|collection|description|gene_count","mappings":[{"input":"HGNC:1582","source":"HGNC:1582|cyclin D1","targets":["M10003|GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_UP|C7|Genes up-regulated during primary acute viral infection in dendritic cells: CD8A [GeneID=925] versus ITGAM+ [GeneID=3684].|198","M10007|GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN|C7|Genes down-regulated during primary acute viral infection in dendritic cells with IFNAR1 [GeneID=3454] knockout: CD8A [GeneID=925] versus ITGAM+ [GeneID=3684].|194","M10112|RNGTGGGC_UNKNOWN|C3:TFT|Genes having at least one occurrence of the highly conserved motif M140 RNGTGGGC in the regions spanning 4 kb centered on their transcription starting sites [-2kb,+2kb].  The motif does not match any known transcription factor binding site.|783","M10189|REACTOME_SIGNALING_BY_NOTCH|C2:CP|Signaling by NOTCH|241","M10221|GOBP_RESPONSE_TO_ETHANOL|C5:GO|Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus. [GOC:go_curators]|124","M10229|GOBP_NEGATIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS|C5:GO|Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons. [GOC:go_curators, GOC:mtg_apoptosis]|181","M10249|GOBP_HEPATICOBILIARY_SYSTEM_DEVELOPMENT|C5:GO|The progression of the hepaticobiliary system over time, from its formation to the mature structure. The hepaticobiliary system is responsible for metabolic and catabolic processing of small molecules absorbed from the blood or gut, hormones and serum proteins, detoxification, storage of glycogen, triglycerides, metals and lipid soluble vitamins and excretion of bile. Included are the synthesis of albumin, blood coagulation factors, complement, and specific binding proteins. [GOC:dph]|145","M10262|GOBP_RESPONSE_TO_IONIZING_RADIATION|C5:GO|Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ionizing radiation stimulus. Ionizing radiation is radiation with sufficient energy to remove electrons from atoms and may arise from spontaneous decay of unstable isotopes, resulting in alpha and beta particles and gamma rays. Ionizing radiation also includes X-rays. [PMID:12509526]|146","M10268|GOBP_EPITHELIUM_DEVELOPMENT|C5:GO|The process whose specific outcome is the progression of an epithelium over time, from its formation to the mature structure. An epithelium is a tissue that covers the internal or external surfaces of an anatomical structure. [GOC:dph, GOC:mtg_lung]|1281","M10319|WALLACE_PROSTATE_CANCER_RACE_UP|C2|Genes up-regulated in prostate cancer samples from African-American patients compared to those from the European-American patients.|303","M10351|BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN|C2|Genes down-regulated in T24 (bladder cancer) cells in response to the photodynamic therapy (PDT) stress.|646","M10463|GOBP_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION|C5:GO|Any process that modulates the frequency, rate or extent of mammary gland epithelial cell proliferation. [GOC:mah]|16","M105|PID_TELOMERASE_PATHWAY|C2:CP|Regulation of Telomerase|67","M10509|GOBP_RESPONSE_TO_ESTRADIOL|C5:GO|Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen. [GOC:mah, ISBN:0911910123]|113","M10573|SWEET_KRAS_ONCOGENIC_SIGNATURE|C2|Genes that contributed maximally to the GSEA score of the up-regulated gene set from the KrasLA mouse model in two human lung cancer expression data sets comparing mutant vs normal KRAS [GeneID=3845].|89","M10582|STAEGE_EWING_FAMILY_TUMOR|C2|Genes up-regulated in Ewing family tumors (EFT) compared with normal bone marrow samples.|32","M1060|REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM|C2:CP|Cytokine Signaling in Immune system|785","M10764|GOBP_RESPONSE_TO_CORTICOSTEROID|C5:GO|Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a corticosteroid hormone stimulus. A corticosteroid is a steroid hormone that is produced in the adrenal cortex. Corticosteroids are involved in a wide range of physiologic systems such as stress response, immune response and regulation of inflammation, carbohydrate metabolism, protein catabolism, blood electrolyte levels, and behavior. They include glucocorticoids and mineralocorticoids. [GOC:mah, PMID:11027914]|153","M10783|HOFMANN_CELL_LYMPHOMA_UP|C2|Genes up-regulated in lymph nodes from patients with mantle cell lymphoma (MCL) compared to the non-malignant hyperplastic lymph nodes.|48","M10797|AMIT_EGF_RESPONSE_60_HELA|C2|Genes whose expression peaked at 60 min after stimulation of HeLa cells with EGF [GeneID=1950].|47","M1081|REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21|C2:CP|SCF(Skp2)-mediated degradation of p27/p21|50","M10821|TTTGTAG_MIR520D|C3:MIR|Genes having at least one occurence of the motif TTTGTAG in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-520d* (v7.1 miRBase).|335","M10844|GOBP_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS|C5:GO|Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stress acting at the endoplasmic reticulum. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen. [GOC:cjm, GOC:mah]|283","M10873|ATACCTC_MIR202|C3:MIR|Genes having at least one occurence of the motif ATACCTC in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-202 (v7.1 miRBase).|178","M10968|GOBP_MAMMARY_GLAND_EPITHELIUM_DEVELOPMENT|C5:GO|The process whose specific outcome is the progression of the mammary gland epithelium over time, from its formation to the mature structure. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk. [GOC:dph, GOC:yaf]|74","M11012|GOBP_CELL_CYCLE_PHASE_TRANSITION|C5:GO|The cell cycle process by which a cell commits to entering the next cell cycle phase. [GOC:mtg_cell_cycle]|570","M11049|GOBP_POSITIVE_REGULATION_OF_MITOTIC_CELL_CYCLE|C5:GO|Any process that activates or increases the rate or extent of progression through the mitotic cell cycle. [GOC:dph, GOC:go_curators, GOC:tb]|136","M11106|BIOCARTA_GSK3_PATHWAY|C2:CP|Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages|20","M1117|CAIRO_PML_TARGETS_BOUND_BY_MYC_DN|C2|Genes down-regulated in MEF cells (embryonic fibroblasts) after knockout of PML [GeneID=5371] and whose promoters were bound by MYC [GeneID=4609].|13","M1120|JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP|C2|Genes up-regulated in brain tumors induced by retroviral delivery of PDGFB [GeneID=5155].|57","M11238|LINDGREN_BLADDER_CANCER_CLUSTER_3_DN|C2|Genes whose expression profile is specific to Cluster III of urothelial cell carcinoma (UCC) tumors.|226","M1126|HUMMERICH_MALIGNANT_SKIN_TUMOR_UP|C2|Genes up-regulated in malignant skin tumors (squamous cell carcinoma, SCC) formed by treatment with DMBA and TPA [PubChem=6001;4792] in the two stage skin carcinogenesis model.|18","M11315|GOBP_REGENERATION|C5:GO|The regrowth of a lost or destroyed body part, such as an organ or tissue. This process may occur via renewal, repair, and/or growth alone (i.e. increase in size or mass). [GOC:mah, GOC:pr]|192","M11350|KYNG_DNA_DAMAGE_DN|C2|Genes with GO annotation and down-regulated after DNA damage in cell lines from young donors.|182","M11351|GOBP_NEUROGENESIS|C5:GO|Generation of cells within the nervous system. [GO_REF:0000021, GOC:cls, GOC:curators, GOC:dgh, GOC:dph, GOC:jid]|1821","M11512|FOXO1_01|C3:TFT|Genes having at least one occurrence of the motif NRWAAACAAN in the regions spanning 4 kb centered on their transcription starting sites [-2kb, +2kb].  This matches the FOXO1A [GeneSymbol=FOXO1A] transcription factor binding site V$FOXO1_01 (v7.4 TRANSFAC).|248","M1163|BAKER_HEMATOPOIESIS_STAT3_TARGETS|C2|STAT3 [GeneID=6774] targets in hematopoietic signaling.|15","M1165|BAKER_HEMATOPOESIS_STAT5_TARGETS|C2|STAT5 [GeneID=6777] targets in hematopoietic signaling.|7","M11664|chr11q13|C1|Ensembl 114 genes in cytogenetic band chr11q13|458","M11682|BONCI_TARGETS_OF_MIR15A_AND_MIR16_1|C2|Potential targets of MIR15A and MIR16-1 [GeneID=406948;406950] microRNAs in prostate cancer.|92","M11698|YY1_Q6|C3:TFT|Genes having at least one occurrence of the motif GCCATNTTN in the regions spanning 4 kb centered on their transcription starting sites [-2kb, +2kb].  This matches the YY1 [GeneSymbol=YY1] transcription factor binding site V$YY1_Q6 (v7.4 TRANSFAC).|251","M11720|BEIER_GLIOMA_STEM_CELL_DN|C2|Genes down-regulated in cancer stem cells derived from glyoblastoma tumors: CD133+ [GeneID=8842]  vs. CD133- cells.|66","M11772|GOCC_MICROTUBULE_ORGANIZING_CENTER|C5:GO|An intracellular structure that can catalyze gamma-tubulin-dependent microtubule nucleation and that can anchor microtubules by interacting with their minus ends, plus ends or sides. [GOC:vw, ISBN:0815316194, PMID:17072892, PMID:17245416, Wikipedia:Microtubule_organizing_center]|974","M11801|GOBP_POSITIVE_REGULATION_OF_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE|C5:GO|Any signaling pathway that increases or activates a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the mitotic cell cycle. [GOC:mtg_cell_cycle]|56","M11845|GOBP_CELLULAR_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN|C5:GO|Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a protein that is not folded in its correct three-dimensional structure. [GOC:bf]|117","M1191|HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN|C2|Genes down-regulated in MDA-MB-231 cells (breast cancer, mutated TP53 [GeneID=7157]) undergoing aberrant mitosis and necrosis after treatment with 2 nM docetaxel [PubChem=148124].|22","M11938|GOBP_RESPONSE_TO_METAL_ION|C5:GO|Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a metal ion stimulus. [GOC:sm]|348","M12021|GOBP_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION|C5:GO|Any signaling pathway that modulates the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G2 phase to M phase of the cell cycle. [GO_REF:0000058, GOC:jl, GOC:TermGenie]|122","M12058|GOBP_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION|C5:GO|Any process that modulates the frequency, rate or extent of epithelial cell differentiation. [GOC:mah]|177","M12088|GOMF_KINASE_ACTIVATOR_ACTIVITY|C5:GO|Binds to and increases the activity of a kinase, an enzyme which catalyzes of the transfer of a phosphate group, usually from ATP, to a substrate molecule. [GOC:ai]|159","M12099|GOBP_RESPONSE_TO_MAGNESIUM_ION|C5:GO|Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a magnesium ion stimulus. [GOC:mah]|19","M12129|GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION|C5:GO|Any signaling pathway that activates or increases the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G2 phase to M phase of the cell cycle. [GO_REF:0000058, GOC:jl, GOC:TermGenie]|30","M12144|BROWNE_HCMV_INFECTION_48HR_DN|C2|Genes down-regulated in primary fibroblast cell culture after infection with HCMV (AD169 strain) at 48 h time point that were not down-regulated at the previous time point, 24 h.|481","M1218|BORLAK_LIVER_CANCER_EGF_UP|C2|Genes up-regulated in hepatocellular carcinoma (HCC) developed by transgenic mice overexpressing a secretable form of EGF [GeneID=1950] in liver.|54","M12224|MARTINEZ_RB1_TARGETS_UP|C2|Genes up-regulated in mice with skin specific knockout of RB1 [GeneID=5925] by Cre-lox.|685","M12294|KEGG_VIRAL_MYOCARDITIS|C2:CP|Viral myocarditis|70","M12297|CDP_01|C3:TFT|Genes having at least one occurrence of the motif CCAATAATCGAT in the regions spanning 4 kb centered on their transcription starting sites [-2kb, +2kb].  This matches the CUTL1 [GeneSymbol=CUTL1] transcription factor binding site V$CDP_01 (v7.4 TRANSFAC).|95","M123|MUELLER_PLURINET|C2|Genes constituting the PluriNet protein-protein network shared by the pluripotent cells (embryonic stem cells, embryonical carcinomas and induced pluripotent cells).|299","M1233|OHM_METHYLATED_IN_ADULT_CANCERS|C2|Genes showing frequent DNA methylation and which are silenced in adult cancers but remain unmethylated in embryonic carcinoma and embryonic stem (ES) cells.|27","M12427|GOBP_LEYDIG_CELL_DIFFERENTIATION|C5:GO|The process in which a relatively unspecialized cell acquires specialized structural and/or functional features of a Leydig cell. A Leydig cell is a testosterone-secreting cell in the interstitial area, between the seminiferous tubules, in the testis. [GOC:ln, PMID:12050120]|11","M12456|VERNELL_RETINOBLASTOMA_PATHWAY_DN|C2|Cluster 2: genes down-regulated by RB1, CDNK2A [GeneID=1029;5925], and one of the E2Fs (E2F1, E2F2, or E2F3 [GeneID=1869;1870;1871]).|22","M12573|GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_PROCESS|C5:GO|Any process that decreases the rate, frequency or extent of a cellular process that is involved in the progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. [GOC:dph, GOC:tb]|317","M12636|RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP|C2|Genes up-regulated in peripheral blood monocytes by CSF2RB (GM-CSF) and IL4 [GeneID=1437;3565].|341","M1275|SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2|C2|Cluster PAM2: genes up-regulated in hepatocellular carcinoma (HCC) vs normal liver tissue from mice deficient for TXNIP [GeneID=10628].|168","M12778|GOBP_REPRODUCTIVE_SYSTEM_DEVELOPMENT|C5:GO|The progression of the reproductive system over time from its formation to the mature structure. The reproductive system consists of the organs that function in reproduction. [GOC:dph]|322","M12802|SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS|C2|Genes from the recurrent amplicons in 89 samples of oral squamous cell carcinoma (SCC).|37","M12804|LE_EGR2_TARGETS_UP|C2|Genes up-regulated in P14 nerves of transgenic mice having hypomorhic (reduced function) allele of EGR2 [GeneID=1959].|110","M12822|GOBP_RESPONSE_TO_KETONE|C5:GO|A response that results in a state of tolerance to ketone. [GOC:mengo_curators, PMID:23356676]|226","M12826|ATF1_Q6|C3:TFT|Genes having at least one occurrence of the motif CYYTGACGTCA in the regions spanning 4 kb centered on their transcription starting sites [-2kb, +2kb].  This matches the ATF1 [GeneSymbol=ATF1] transcription factor binding site V$ATF1_Q6 (v7.4 TRANSFAC).|238","M12829|GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE|C5:GO|Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle. [GOC:dph, GOC:go_curators, GOC:tb]|398","M12868|KEGG_PATHWAYS_IN_CANCER|C2:CP|Pathways in cancer|325","M12880|YY1_02|C3:TFT|Genes having at least one occurrence of the motif NNNCGGCCATCTTGNCTSNW in the regions spanning 4 kb centered on their transcription starting sites [-2kb, +2kb].  This matches the YY1 [GeneSymbol=YY1] transcription factor binding site V$YY1_02 (v7.4 TRANSFAC).|251","M12892|SMID_BREAST_CANCER_LUMINAL_B_UP|C2|Genes up-regulated in the luminal B subtype of breast cancer.|170","M12934|BRN2_01|C3:TFT|Genes having at least one occurrence of the motif NNCATNSRWAATNMRN in the regions spanning 4 kb centered on their transcription starting sites [-2kb, +2kb].  This matches the POU3F2 [GeneSymbol=POU3F2] transcription factor binding site V$BRN2_01 (v7.4 TRANSFAC).|240","M1298|GROSS_ELK3_TARGETS_UP|C2|Genes up-regulated in SEND cells (skin endothelium) at normal oxygen (normoxia) conditions after knockdown of ELK3 [GeneID=2004] by RNAi.|27","M13008|DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN|C2|Genes exclusively down-regulated in fibroblasts expressing the TTD mutant form of ERCC3 [GeneID=2071], after UVC irradiation.|84","M13014|ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN|C2|Genes down-regulated in liver tumor compared to the normal adjacent tissue.|274","M1303|GROSS_HYPOXIA_VIA_ELK3_UP|C2|Genes up-regulated in SEND cells (skin endothelium) at hypoxia with ELK3 [GeneID=2004] knockdown by RNAi.|209","M13164|CCTGTGA_MIR513|C3:MIR|Genes having at least one occurence of the motif CCTGTGA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-513 (v7.1 miRBase).|125","M13170|GOBP_REGULATION_OF_CELL_CYCLE|C5:GO|Any process that modulates the rate or extent of progression through the cell cycle. [GOC:ai, GOC:dph, GOC:tb]|1114","M1318|GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN|C2|Genes down-regulated in SEND cells (skin endothelium) at hypoxia after knockdown of ELK3 [GeneID=2004] and HIF1A [GeneID=3091] by RNAi.|103","M13191|KEGG_PROSTATE_CANCER|C2:CP|Prostate cancer|89","M13194|MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23|C2|Amplification hot spot 23: colocolized fragile sites and cancer genes in the 11q12-q25 region.|19","M13279|HFH8_01|C3:TFT|Genes having at least one occurrence of the motif NNNTGTTTATNTR in the regions spanning 4 kb centered on their transcription starting sites [-2kb, +2kb].  This matches the FOXJ1 [GeneSymbol=FOXJ1] transcription factor binding site V$HFH8_01 (v7.4 TRANSFAC).|208","M13282|GOBP_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION|C5:GO|Any signaling pathway that modulates the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the cell cycle. [GO_REF:0000058, GOC:mtg_cell_cycle, GOC:TermGenie]|206","M133|TCF11_01|C3:TFT|Genes having at least one occurrence of the motif GTCATNNWNNNNN in the regions spanning 4 kb centered on their transcription starting sites [-2kb, +2kb].  This matches the NFE2L1 [GeneSymbol=NFE2L1] transcription factor binding site V$TCF11_01 (v7.4 TRANSFAC).|258","M13340|GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_PROCESS|C5:GO|Any process that increases the rate, frequency or extent of a cellular process that is involved in the progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. [GOC:dph, GOC:tb]|275","M1341|HFH4_01|C3:TFT|Genes having at least one occurrence of the motif AWKTGTTTGTTTA in the regions spanning 4 kb centered on their transcription starting sites [-2kb, +2kb].  This matches the FOXJ1 [GeneSymbol=FOXJ1] transcription factor binding site V$HFH4_01 (v7.4 TRANSFAC).|205","M13413|GOBP_CELL_CYCLE_G1_S_PHASE_TRANSITION|C5:GO|The cell cycle process by which a cell in G1 phase commits to S phase. [GOC:mtg_cell_cycle]|272","M13445|GOBP_LIVER_REGENERATION|C5:GO|The regrowth of lost or destroyed liver. [GOC:gap, PMID:19447520]|27","M13475|GOBP_RESPONSE_TO_ESTROGEN|C5:GO|Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics. [GOC:jl, ISBN:0198506732]|65","M13508|GOBP_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE|C5:GO|Any process that stops, prevents or reduces the rate or extent of progression through the mitotic cell cycle. [GOC:dph, GOC:go_curators, GOC:tb]|245","M13551|AAAGACA_MIR511|C3:MIR|Genes having at least one occurence of the motif AAAGACA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNA hsa-miR-511 (v7.1 miRBase).|204","M13558|GOBP_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND|C5:GO|Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an oxygen-containing compound stimulus. [GOC:pr, GOC:TermGenie]|1726","M13573|GOBP_RESPONSE_TO_UV|C5:GO|Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultraviolet radiation (UV light) stimulus. Ultraviolet radiation is electromagnetic radiation with a wavelength in the range of 10 to 380 nanometers. [GOC:hb]|158","M13582|GOBP_SECRETION|C5:GO|The controlled release of a substance by a cell or a tissue. [GOC:ai]|1016","M13600|OCT1_07|C3:TFT|Genes having at least one occurrence of the motif TNTATGBTAATT in the regions spanning 4 kb centered on their transcription starting sites [-2kb, +2kb].  This matches the POU2F1 [GeneSymbol=POU2F1] transcription factor binding site V$OCT1_07 (v7.4 TRANSFAC).|168","M13636|GOBP_DNA_DAMAGE_RESPONSE|C5:GO|Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to its DNA from environmental insults or errors during metabolism. [GOC:go_curators]|938","M13646|GOBP_RESPONSE_TO_RADIATION|C5:GO|Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electromagnetic radiation stimulus. Electromagnetic radiation is a propagating wave in space with electric and magnetic components. These components oscillate at right angles to each other and to the direction of propagation. [GOC:jl, Wikipedia:Electromagnetic_radiation]|461","M13712|GOBP_MITOTIC_DNA_INTEGRITY_CHECKPOINT_SIGNALING|C5:GO|A signaling process that controls cell cycle progression in response to changes in DNA structure by monitoring the integrity of the DNA during mitosis. The DNA integrity checkpoint begins with detection of DNA damage, defects in DNA structure or DNA replication, and ends with signal transduction. [GOC:mtg_cell_cycle]|75"]}]}